Literature DB >> 20972932

[Multiparametric MRI of the prostate: method for early detection of prostate cancer?].

H-P Schlemmer1.   

Abstract

Current approaches for the early detection of prostate cancer are controversially discussed because the disease is characterized by a high incidence rate with a relatively low morbidity rate, availability of only limited prognostic markers, and continued therapy-related morbidity. Conventional morphological MRI does not play a role in early detection since small tumor foci cannot be delineated. However, if there is clinical suspicion for prostate cancer, multiparametric MRI is currently the most accurate method for detecting and characterizing suspicious lesions in the prostate. The potential to identify the so-called "index lesion", i. e., the tumor area that is most aggressive and determines treatment, is particularly important. This information can increase the accuracy of prostate biopsy and serve as a biomarker for follow-up during active surveillance. The method may considerably contribute to the urgently required separation of clinically significant from clinically insignificant prostate cancers. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972932     DOI: 10.1055/s-0029-1245786

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  5 in total

1.  Feasibility study of computed vs measured high b-value (1400 s/mm²) diffusion-weighted MR images of the prostate.

Authors:  Leonardo K Bittencourt; Ulrike I Attenberger; Daniel Lima; Ralph Strecker; Andre de Oliveira; Stefan O Schoenberg; Emerson L Gasparetto; Daniel Hausmann
Journal:  World J Radiol       Date:  2014-06-28

2.  Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values.

Authors:  Gregor Thörmer; Josephin Otto; Martin Reiss-Zimmermann; Matthias Seiwerts; Michael Moche; Nikita Garnov; Toni Franz; Minh Do; Jens-Uwe Stolzenburg; Lars-Christian Horn; Thomas Kahn; Harald Busse
Journal:  Eur Radiol       Date:  2012-04-17       Impact factor: 5.315

3.  Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: a retrospective data analysis.

Authors:  Friedrich Aigner; Georg Schäfer; Eberhard Steiner; Werner Jaschke; Wolfgang Horninger; Thomas R W Herrmann; Udo Nagele; Ethan J Halpern; Ferdinand Frauscher
Journal:  World J Urol       Date:  2011-12-18       Impact factor: 4.226

4.  [Potential of PET/MRI for diagnosis of prostate cancer].

Authors:  M C Röthke; A Afshar-Oromieh; H-P Schlemmer
Journal:  Radiologe       Date:  2013-08       Impact factor: 0.635

5.  Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer.

Authors:  Daniel Junker; Georg Schäfer; Michael Edlinger; Christian Kremser; Jasmin Bektic; Wolfgang Horninger; Werner Jaschke; Friedrich Aigner
Journal:  Biomed Res Int       Date:  2013-12-16       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.